EnClear Therapies
PrivateLast Round
VC Round
Sep 4, 2024
Total Funding Raised
$13.3M
Company Overview
EnClear Therapies is a biotechnology company that develops device-based therapies designed to treat neurological diseases. The company's platform removes toxic proteins from cerebrospinal fluid (CSF) and provides controlled delivery of therapeutics to the central nervous system.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EnClear Therapies Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
EnClear Therapies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 4, 2024 | ||||
| Grant | Jan 1, 2024 | ||||
| Series A | Feb 19, 2020 | ||||
| Seed | Mar 14, 2019 |
EnClear Therapies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Dolby Family Ventures | Series A |
| Thiel Capital | Seed |
| Founders Fund | VC Round |
| Thiel Bio | VC Round |
| Bioverge | Seed, VC Round |
| Presight Capital | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 27, 2024
Monthly visitors increased 207% MoM.
- Sep 4, 2024
Led by Sontag Innovation Fund and The Brain Tumor Investment Fund.
EnClear Therapies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EnClear Therapies's valuation, stock price, and market status.